Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

April 07, 2026 21:49 ET | Source: Leanzene

Leanzene Claims Evaluated: The Leading Keto BHB + ACV Weight Loss Gummy Brand on the Market

Leanzene BHB + ACV gummy claims evaluated: ingredient research, proprietary blend transparency, label vs. marketing analysis for consumers 2026
April 07, 2026 18:50 ET | Source: Robbins Geller Rudman & Dowd LLP

MEDP INVESTOR ALERT: Medpace Holdings Inc. Investors with Substantial Losses Have Opportunity to Lead the Medpace Class Action Lawsuit – RGRD Law

The case alleges Medpace oversold its projected book-to-bill ratio for fourth quarter 2025.
April 07, 2026 16:50 ET | Source: NovaBridge Biosciences

NovaBridge Reports Full Year 2025 Financial Results and Provides Business Update

Successful transformation to global biotech platform with two mid-stage potential best-in-class/first-in-class programs, givastomig and VIS-101, with compelling proof-of-concept dataGivastomig, a...
April 07, 2026 16:15 ET | Source: Nanobiotix S.A.

Voting Rights and Shares Capital of the Company

PARIS, April 07, 2026 (GLOBE NEWSWIRE) -- Market: Euronext Paris / NasdaqEuronext Compartment: B ISIN code: FR0011341205Nasdaq: NBTXBloomberg: NANO:FPReuters: NANO.PAWebsite: www.nanobiotix.com...
April 07, 2026 15:46 ET | Source: Pomerantz LLP

Pomerantz Law Firm Announces the Filing of a Class Action Against Inovio Pharmaceuticals, Inc. and Certain Officers – INO

NEW YORK, April 07, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Inovio Pharmaceuticals, Inc. (“Inovio” or the “Company”) (NASDAQ: INO) and...
April 07, 2026 13:44 ET | Source: BCC Research LLC

Global DNA Read, Write and Edit Market to Surge to $67.7 Billion by 2030, Driven by CRISPR Advances, Genomic Diagnostics and Expanding Clinical Applications

Rapid expansion in clinical applications, rising demand for genomic diagnostics, and increased investment in CRISPR-based therapeutics are fueling demand.
April 07, 2026 12:13 ET | Source: Research and Markets

Purvalanol A (CDK Inhibitor) Market Report 2026: Expanding Molecular Biology and Cancer Research Fuelling Market Growth

Dublin, April 07, 2026 (GLOBE NEWSWIRE) -- The "Purvalanol A (CDK Inhibitor) Market Report 2026" has been added to ResearchAndMarkets.com's offering. The Purvalanol A (CDK Inhibitor) market has...
April 07, 2026 12:01 ET | Source: Research and Markets

Messenger RNA (mRNA) Market Projected to Reach $20.99 Billion by 2035 - Moderna, Pfizer, and Others Propel mRNA Expansion into New Therapeutic Areas

Dublin, April 07, 2026 (GLOBE NEWSWIRE) -- The "Messenger RNA Market - A Global and Regional Analysis: Application and Regional Analysis - Analysis and Forecast, 2025-2035" has been added to ...
April 07, 2026 11:45 ET | Source: Transgene S.A.

Transgene to Participate in Upcoming Investor Meetings

Transgene to Participate in Upcoming Investor Meetings
April 07, 2026 10:30 ET | Source: Exousia Pro, Inc.

NexTel Medical Corp Announces Pivotal Milestone in Commercial Launch of Patent-Protected NANOG DNA Cancer Screening Test

Exousia Pro, OTCPK: MAJI, announces the commencement of the first critical phase in bringing its revolutionary cancer screening test to the global market.